En Es
Categories

Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research, and food safety. The company’s open-architecture xMAP technolog ...
Products Covid-19NewsSummary
Close

Covid-19 Luminex Corporation

Clinical Laboratory

Respiratory Pathogen Panel + SARS-CoV-2
NxTAG Respiratory Pathogen Panel + SARS-CoV-2

The NxTAG Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG RPP + SARS‑CoV‑2), developed for use on the NxTAG-Enabled MAGPIX® System, is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs. The formulation of the assay is identical to NxTAG RPP, with the exception of the additional reagents required for the detection of SARS‑CoV‑2. No changes have been made to the existing NxTAG RPP reagents, reaction conditions, workflow, or software thresholds; therefore, the performance characteristics of NxTAG RPP are still applicable to NxTAG RPP + SARS‑CoV‑2.
More details

SARS-CoV-2 Test
NxTAG CoV Extended Panel

The NxTAG CoV Extended Panel offers SARS-CoV-2 detection using three viral genes (ORF1ab, E gene, and N gene), enabling accurate, reliable results. It is a highly scalable, cost-effective solution that can process up to 96 samples in approximately four hours and was developed for use on the MAGPIX NxTAG-enabled System. It has received Emergency Use Authorization (EUA) from the US FDA and Medical Device Authorization for Importation or Sale for Health Canada.
More details

SARS-CoV-2 Test
ARIES SARS-CoV-2 Assay

The ARIES SARS-CoV-2 Assay is a moderate-complexity, sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs. It allows for minimal hands-on time and an automated workflow deliver results in about two hours. Additionally, exonuclease-sensitive probes for the ORF1ab and N viral genes provide superior specificity.
More details

SARS-CoV2 Antibody Test
xMAP SARS-CoV-2 Multi-Antigen IgG Assay

The xMAP SARS-CoV-2 Multi-Antigen IgG Assay is a multiplex, microsphere-based, highly sensitive and specific assay that detects the presence or absence of antibodies against three different SARS-CoV-2 antigens. By using a combination of robust internal controls and highly-specific antigens, the assay may provide earlier, more sensitive results.
More details
Close

News of Luminex Corporation

DiaSorin Completes Acquisition of Luminex to Become a Full-Fledged Diagnostic and Life Science Player

16 Jul 2021
DiaSorin Completes Acquisition of Luminex to Become a Full-Fledged Diagnostic and Life Science Player
DiaSorin S.p.A. (?Saluggia?, Italy) has completed the acquisition of Luminex Corporation (Austin, TX, USA), allowing it to gain access to Luminex’s multiplexing technology and a portfolio that will strengthen its existing offering, while expanding the Group presence in the US.
Read More

DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space

13 Apr 2021
DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space
DiaSorin S.p.A. (?Saluggia?, Italy) has announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (Austin, TX, USA) for approximately USD 1.8 billion.
Read More
Close

About Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research, and food safety. The company’s open-architecture xMAP technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.
FaceBook Twitter Google+ Linked in
In Vitro Diagnostic System

In Vitro Diagnostic System

Model: ARIES M1
Request Information

Description:

The ARIES M1 is a fully integrated, sample to answer platform for performing real-time PCR assays with features such as an intuitive system interface, STAT or batch testing, and true walkaway capability. It extracts, amplifies and detects nucleic acid targets from a variety of sample types, and can process up to six different samples, and one to six assays, at a time, making it ideal for lower throughput clinical labs.


Send A Message To This Supplier

* Required Information
* Email
To
Luminex Corporation (In Vitro Diagnostic System)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions